Introduction
PSMA PET-CT (Prostate-Specific Membrane Antigen Positron Emission Tomography – Computed Tomography) is an advanced molecular imaging technique specifically designed for the evaluation of prostate cancer.
It detects prostate cancer cells with high sensitivity by targeting PSMA, a protein that is overexpressed on the surface of most prostate cancer cells.
By combining highly specific functional imaging with detailed anatomical CT images, PSMA PET-CT enables accurate localization of prostate cancer, even at very low disease levels.
It plays a critical role in initial staging, detection of recurrence, and treatment planning for patients with prostate cancer.
Türkiye is a trusted destination for advanced nuclear medicine diagnostics, offering modern PSMA PET-CT technology, experienced specialists, and integrated urologic oncology care.
Averia Health supports international patients through ethical, structured, and fully coordinated PSMA PET-CT services focused on accuracy, safety, and clinical decision support.
Why Choose Türkiye for PSMA PET-CT
Türkiye is internationally recognized for high-quality PSMA PET-CT imaging because of:
- Advanced PET-CT scanners optimized for prostate cancer imaging
- Availability of PSMA-targeted radiotracers
- Experienced nuclear medicine physicians and radiologists
- Strict radiation safety and quality assurance standards
- Multidisciplinary collaboration with urology, oncology, and radiation oncology teams
- Internationally accredited hospitals
Türkiye combines cutting-edge imaging technology with specialized oncologic expertise.
Why Choose Averia Health
Averia Health provides comprehensive coordination for PSMA PET-CT scans:
- Pre-arrival review of medical history, PSA levels, and prior imaging
- Referral to accredited nuclear medicine centers experienced in PSMA imaging
- Clear explanation of the procedure and preparation requirements
- Coordination with urology and oncology specialists
- Professional interpreter services
- 24/7 patient support during your visit
- Timely reporting and international follow-up coordination
Our approach prioritizes diagnostic precision, transparency, and patient reassurance.
Conditions Evaluated with PSMA PET-CT
PSMA PET-CT is primarily used for:
- Initial staging of newly diagnosed prostate cancer
- Detection of prostate cancer recurrence after surgery or radiation
- Localization of disease in patients with rising PSA levels
- Assessment of lymph node involvement
- Detection of bone and soft tissue metastases
- Treatment planning for surgery, radiotherapy, or systemic therapy
It is especially valuable when conventional imaging is inconclusive.
Types of PSMA PET-CT Applications
Initial Prostate Cancer Staging
Identifies the extent of disease at diagnosis.
Biochemical Recurrence Evaluation
Detects recurrent cancer at low PSA levels.
Metastatic Disease Assessment
Accurately maps spread to lymph nodes or bones.
Treatment Planning and Response Assessment
Guides targeted therapy and radiation planning.
The scan protocol is tailored to the patient’s clinical scenario.
Diagnostic Evaluation Before PSMA PET-CT
Preparation and evaluation may include:
- Review of PSA levels and prostate cancer history
- Review of prior imaging (MRI, CT, bone scan)
- Hydration instructions before the scan
- Medication and medical history review
- Assessment for pregnancy or breastfeeding when relevant
Proper preparation ensures optimal scan accuracy.
PSMA PET-CT Scan Journey in Türkiye
- Pre-Arrival Case Review
Medical records, PSA history, and imaging indications are reviewed. - Nuclear Medicine Consultation
The procedure and expectations are explained clearly. - PSMA Tracer Administration
A small, targeted radiotracer is administered safely. - PSMA PET-CT Imaging
Whole-body imaging is performed using advanced PET-CT systems. - Image Interpretation
Results are analyzed by experienced nuclear medicine specialists. - Results & Care Coordination
Findings are shared with your treating physician to guide next steps.
Expected Results & Benefits
- Highly sensitive detection of prostate cancer
- Accurate disease staging and localization
- Early identification of recurrence
- Improved treatment planning and targeting
- Reduced uncertainty when conventional imaging is negative
PSMA PET-CT significantly enhances clinical decision-making in prostate cancer care.
Risks & Considerations
PSMA PET-CT is safe and well established. Considerations include:
- Exposure to a low level of radiation
- Temporary discomfort from tracer injection
- Need to follow preparation instructions carefully
Radiation exposure is minimized and justified by the diagnostic benefit.
What’s Included in Your Medical Visit
- PSMA PET-CT scan appointment
- Nuclear medicine consultation
- PSMA radiotracer administration
- PET-CT imaging and expert interpretation
- Written diagnostic report
- Coordination with urology or oncology teams
- Interpreter services
- Patient support and follow-up coordination
Averia Health ensures ethical, precise, and patient-centered prostate cancer imaging care.
Frequently Asked Questions
What makes PSMA PET-CT different from standard PET-CT?
It targets PSMA, making it far more specific for prostate cancer.
Can PSMA PET-CT detect cancer at low PSA levels?
Yes. It is highly sensitive, even when PSA levels are low.
Is PSMA PET-CT safe?
Yes. Radiation exposure is controlled and within medical standards.
Do all prostate cancer patients need PSMA PET-CT?
It is recommended based on disease stage, PSA levels, and clinical needs.
How quickly will I receive the results?
Results are typically available shortly after expert interpretation.
Ready to Start Your Health Journey?
Gain precise insight into prostate cancer with advanced PSMA PET-CT imaging in Türkiye.
Request a case review or contact us on WhatsApp to speak with our diagnostic care coordination team.
